/ Company / People / Chris Thomajan
chris-thomajan

Expertise

  • Finance & Accounting

Role

  • CFO

Location

  • Boston

Chris Thomajan

Managing Partner - Boston

Chris Thomajan has been a CFO for over 30 years in a variety of industries, including: biotech, medtech, software, digital media, Internet services and investment banking.

Chris was a founding partner of America’s Growth Capital, a boutique investment bank focused on emerging growth technology companies. He was the early stage CFO/VP Operations for Asurion Corporation which is a closely held, multi-billion-dollar private company. He was also the founding CFO for a pioneering Internet company, Delphi Internet Services, which was acquired by News Corporation in 1993.

Since joining TechCXO in 2007, Chris has worked with outstanding companies such as Cyteir Therapeutics (CYT – IPO in 2021), Decibel Therapeutics (DBTX – IPO in 2021), Relay Therapeutics (RLAY – IPO in 2020), Keros Therapeutics (KROS – IPO in 2020), Mashable, Mascoma Corp., Adheron (acquired by Roche in 2015), Catabasis Pharmaceuticals (CATB – IPO in 2015), and Ektron (acquired by Accel/KKR in December 2014). Current clients include Valenza Biotech, QurAlis Corporation and EnClear Therapies.

Chris has extensive experience in raising debt and equity. He has also been involved in numerous M&A transactions and has managed the operations of several start-up companies during rapid revenue growth. He received a B.A. from Dartmouth College and an M.B.A. from Columbia University.

Client Portfolio

Successful Transactions by Chris

 

Go to Top